Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide.
暂无分享,去创建一个
S. Kron | Simran S Sabharwal | P. Schumacker | J. Janjic | Masato Suzuki | S. Kozmin | O. Ulanovskaya | S. Sabharwal
[1] O. Warburg. On the origin of cancer cells. , 1956, Science.
[2] W. Prichard,et al. A new class of uncoupling agents--carbonyl cyanide phenylhydrazones. , 1962, Biochemical and biophysical research communications.
[3] J. Brown. Effects of 2-deoxyglucose on carbohydrate metablism: review of the literature and studies in the rat. , 1962, Metabolism: clinical and experimental.
[4] Archie L. Smith. [13] Preparation, properties, and conditions for assay of mitochondria: Slaughterhouse material, small-scale , 1967 .
[5] E. Furuya,et al. Development of mitochondrial membranes in anaerobically grown yeast cells. , 1975, Journal of biochemistry.
[6] P. Mitchell. Protonmotive redox mechanism of the cytochrome b‐c 1 complex in the respiratory chain: Protonmotive ubiquinone cycle , 1975, FEBS letters.
[7] P. Linnett,et al. Inhibitors of the ATP synthethase system. , 1979, Methods in enzymology.
[8] P. Linnett,et al. [59] Inhibitors of the ATP synthetase systems☆ , 1979 .
[9] B. Trumpower,et al. Differential effects of antimycin on ubisemiquinone bound in different environments in isolated succinate . cytochrome c reductase complex. , 1980, The Journal of biological chemistry.
[10] H. Reichenbach,et al. Myxothiazol, a new inhibitor of the cytochrome b-c1 segment of th respiratory chain. , 1981, Biochimica et biophysica acta.
[11] B. Trumpower,et al. An analogue of ubiquinone which inhibits respiration by binding to the iron-sulfur protein of the cytochrome b-c1 segment of the mitochondrial respiratory chain. , 1982, The Journal of biological chemistry.
[12] B. Trumpower,et al. An inhibitor of mitochondrial respiration which binds to cytochrome b and displaces quinone from the iron-sulfur protein of the cytochrome bc1 complex. , 1984, The Journal of biological chemistry.
[13] H. Reichenbach,et al. The mode of action of stigmatellin, a new inhibitor of the cytochrome b-c1 segment of the respiratory chain☆ , 1984 .
[14] Michael J. Shapiro,et al. 1,3-Syn diastereoselective reduction of β-hydroxyketones utilizing alkoxydialkylboranes , 1987 .
[15] M. Carlson,et al. Molecular analysis of the SNF4 gene of Saccharomyces cerevisiae: evidence for physical association of the SNF4 protein with the SNF1 protein kinase , 1989, Molecular and cellular biology.
[16] B. Trumpower. Cytochrome bc1 complexes of microorganisms. , 1990, Microbiological reviews.
[17] B. Trumpower,et al. The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. , 1990, The Journal of biological chemistry.
[18] E. Berry,et al. Ubiquinol-cytochrome c oxidoreductase of higher plants. Isolation and characterization of the bc1 complex from potato tuber mitochondria. , 1991, The Journal of biological chemistry.
[19] C. Debitus,et al. Leucascandrolide A, a New Type of Macrolide: The first powerfully bioactive metabolite of calcareous sponges (Leucascandra caveolata, a new genus from the coral sea) , 1996 .
[20] R. Oballa,et al. Remote, 1,5-anti stereoinduction in the boron-mediated aldol reactions of β-oxygenated methyl ketones , 1996 .
[21] J Deisenhofer,et al. Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. , 1997, Science.
[22] Davidr . Evans,et al. 1,5-Asymmetric Induction in Methyl Ketone Aldol Addition Reactions , 1997 .
[23] M. Carlson,et al. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? , 1998, Annual review of biochemistry.
[24] Sung-Hou Kim,et al. Electron transfer by domain movement in cytochrome bc1 , 1998, Nature.
[25] T. A. Link,et al. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. , 1998, Science.
[26] A. Starkov,et al. Mitochondrial targets of drug toxicity. , 2000, Annual review of pharmacology and toxicology.
[27] Christopher L. Hamblett,et al. Total Synthesis of Leucascandrolide A , 2000 .
[28] S. Rychnovsky,et al. Mukaiyama aldol-Prins cyclization cascade reaction: a formal total synthesis of leucascandrolide A. , 2001, Journal of the American Chemical Society.
[29] N. Savaraj,et al. Hypersensitization of tumor cells to glycolytic inhibitors. , 2001, Biochemistry.
[30] S. Kozmin. Efficient stereochemical relay en route to leucascandrolide A. , 2001, Organic letters.
[31] Ying Wang,et al. Synthesis of leucascandrolide A via a spontaneous macrolactolization. , 2002, Journal of the American Chemical Society.
[32] P. Wipf,et al. A formal total synthesis of leucascandrolide A. , 2002, Chemical communications.
[33] David R. Williams,et al. Formal synthesis of leucascandrolide A. , 2003, Angewandte Chemie.
[34] Awtar Krishan,et al. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions , 2004, Cancer Chemotherapy and Pharmacology.
[35] David R. Williams,et al. Formal synthesis of leucascandrolide A. , 2003, Angewandte Chemie.
[36] Ian Paterson,et al. Stereocontrolled total synthesis of (+)-leucascandrolide A. , 2003, Angewandte Chemie.
[37] B. Trumpower. Cytochrome bc 1 Complexes of Microorganisms , 2003 .
[38] Michael I. Jordan,et al. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[39] B. Trumpower,et al. Inhibition of the Yeast Cytochrome bc1 Complex by Ilicicolin H, a Novel Inhibitor That Acts at the Qn Site of the bc1 Complex* , 2004, Journal of Biological Chemistry.
[40] Michel Roberge,et al. Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[41] M. Crimmins,et al. Enantioselective Total Synthesis of (+)‐Leucascandrolide: A Macrolactone. , 2004 .
[42] Synthesis of leucascandrolide A , 2005 .
[43] J. Panek,et al. Total synthesis of (+)-leucascandrolide A. , 2005, Angewandte Chemie.
[44] Ian Paterson,et al. The Renaissance of Natural Products as Drug Candidates , 2005, Science.
[45] H. Pelicano,et al. Glycolysis inhibition for anticancer treatment , 2006, Oncogene.
[46] Paul S. Ralifo,et al. Total synthesis and stereochemical reassignment of (+)-neopeltolide. , 2007, Angewandte Chemie.
[47] P. Floreancig,et al. Oxidative cleavage in the construction of complex molecules: synthesis of the leucascandrolide A macrolactone. , 2007, Angewandte Chemie.
[48] Peter J McCarthy,et al. Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae. , 2007, Journal of natural products.
[49] P. Capdevielle,et al. Formal Chemoselective Synthesis of Leucascandrolide A. , 2007 .
[50] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[51] K. Scheidt,et al. Total Synthesis and Structural Revision of the Marine Macrolide Neopeltolide. , 2008 .
[52] W. J. Andrews,et al. Synthesis of (+)-Leucascandrolide A Macrolactone , 2009 .